Drug-associated changes in the liver

Current Diagnostic Pathology

Volumn 9, Issue 2, 2003, Pages 96-104

  Tsui, W M S ^a  

^a Caritas Medical Centre Hong Kong   (Hong Kong)

Author keywords

Drug; Hepatotoxicity; Liver; Toxin

Indexed keywords

CHOLESTASIS; CHRONIC LIVER DISEASE; CONFERENCE PAPER; DRUG INDUCED DISEASE; HISTOLOGY; HUMAN; LIVER CANCER; LIVER DISEASE; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY;

EID: 0037389985     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1054/cdip.2003.0162     Document Type: Conference Paper

References (38)

1. Farrell GC. Drug-induced Liver Disease. Edinburgh: Churchill Livingstone, 1994.
2. Stricker BHC. Drug-induced Hepatic Injury, 2nd edn. Amsterdam: Elsevier, 1992.
3. Zimmerman HJ, Ishak KG. Hepatic injury due to drugs and toxins. In MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP (eds). Pathology of the Liver, 4th edn. London: Churchill Livingstone, 2002; 621-709.
4. Pamperl H, Gradner W, Fridrich L, Pointner H, Denk H. Influence of long-term anticonvulsant treatment on liver ultrastructure in man. Liver 1984; 4: 294-300.
5. Vezquez JJ, Guillen FJ, Zozaya J, Lahoz M. Cyanamide-induced liver injury. A predictable lesion. Liver 1983; 3: 225-230.
6. Uchida T, Kao H, Quispe Sjogren M et al. Alcoholic foamy degeneration - a pattern of acute alcoholic injury of the liver. Gastroenterology 1983; 84: 683-692.
7. Peters RL, Edmondson HA, Mikkelsen WP, Tatter D. Tetracycline-induced fatty liver in non-pregnant patients. A report of six cases. Am J Surg 1967; 113: 622-632.
8. Zimmerman HJ, Ishak KG. Valproate-induced hepatic injury: analyses of 23 fatal cases. Hepatology 1982; 2: 591-597.
9. Lewis JH, Mullick F, Ishak KG et al. Histopathologic analysis of suspected amiodarone hepatoxicity. Hum Pathol 1990; 21: 59-67.
10. Munoz SJ, Martinez-Hernandez A, Maddrey WC. Intrahepatic cholestasis and phospholipidosis associated with the use of trimethoprim-sulfamethoxazole. Hepatology 1990; 12: 342-347.
11. Klein S, Nealon WH. Hepatobiliary abnormalities associated with total parenteral nutrition. Semin Liver Dis 1988; 8: 237-246.
12. Welper W, Opitz K. Histological changes in the liver biopsy in Amanita phalloides intoxication. Hum Pathol 1972; 3: 249-254.
13. Portmann B, Talbot IC, Day DW, Davidson AR, Murray-Lyon IM, Williams R. Histopathological changes in the liver following paracetamol overdose: correlation with clinical and biochemical parameters. J Pathol 1975; 117: 169-181.
14. Wanless IR, Dore S, Gopinath N et al. Histopathology of cocaine hepatotoxicity. Report of four patients. Gastroenterology 1990; 98: 497-501.
15. Benjamin SB, Zimmerman HJ, Ishak KG et al. The morphologic spectrum of halothane-induced hepatic injury. Analysis of 77 cases. Hepatology 1985; 5: 1163-1171.
16. Mitchell JR, Zimmerman HJ, Ishak KG et al. Isoniazid liver injury: clinical spectrum, pathology and probable pathogenesis. Ann Intern Med 1976; 84: 181-192.
17. Bianchi L, De Groote J, Desmet V et al. Guidelines for diagnosis of therapeutic drug-induced liver injury in liver biopsies. Review by an international group. Lancet 1974; 1: 854-857.
18. Tsui WMS. New classification of chronic hepatitis and more. Advances Anat Pathol 1996; 3: 64-70.
19. Zimmerman HJ. Drug-induced chronic hepatic disease. Med Clin N Am 1979; 63: 567-582.
20. Ishak KG, Zimmerman HJ. Hepatotoxic effects of the anabolic/androgenic steroids. Semin Liver Dis 1987; 7: 230-236.
21. Ishak KG, Irey NS. Hepatic injury associated with phenothiazines. Clinicopathologic and follow-up study of 36 patients. Arch Pathol 1972; 93: 283-304.
22. Zafrani ES, Ishak KG, Rudzki C. Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases. Am J Dig Dis 1979; 24: 385-396.
23. Mullick FG, Ishak KG, Mahabir R et al. Hepatic injury associated with paraquat toxicity in humans. Liver 1981; 1: 209-221.
24. Devereaux BM, Crawford DH, Purcell P, Powell LW, Roeser HP. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic? Eur J Clin Pharmacol 1995; 49: 81-85.
25. Lok ASF, Ng IOL. Prochlorperazine-induced chronic cholestasis. J Hepatol 1988; 6: 369-373.
26. Desmet JJ. Vanishing bile duct syndrome in drug-induced disease. J Hepatol 1997; 26 (Suppl. 1): 31-35.
27. Ludwig J, Kim CH, Wiesner RH, Krom RA. Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy? Hepatology 1989; 9: 215-218.
28. McMaster KR, Hennigar GR. Drug-induced granulomatous hepatitis. Lab Invest 1981; 44: 61-73.
29. Thomas LB, Popper H, Berk PD, Selikoff I, Falk H. Vinyl chloride induced liver disease. From idiopathic portal hypertension (Banti's syndrome) to angiosarcomas. N Engl J Med 1975; 292: 17-22.
30. Dahl MGC, Gregory MM, Scheuer PJ. Liver damage due to methotrexate in patients with psoriasis. BMJ 1971; 1: 625-630.
31. Leo MA, Lieber CS. Hypervitaminosis A: A liver lover's lament. Hepatology 1988; 8: 412-417.
32. Gitlin N. Drug-induced hepatic vascular abnormalities. Clin Liver Dis 1998; 2: 591-606.
33. Zafrani ES, Pinaudea Y, Dhumeaux D. Drug-induced vascular lesions of the liver. Arch Intern Med 1983; 143: 495-502.
34. Miller EK, Miller JA. Hepatocarcinogenesis by chemicals. Prog Liver Dis 1976; 5: 699-711.
35. Mays ET, Christofferson W. Hepatic tumors induced by sex steroids. Semin Liver Dis 1984; 4: 147-158.
36. Wight DGD. Atlas of Liver Pathology. Lancaster: MTP Press, 1982.
37. Klatskin G, Conn HO. Histopathology of the Liver. New York: Oxford University Press 1993.
38. Scheuer PJ, Lefkowitch JH. Liver Biopsy Interpretation, 6th edn. London: WB Saunders, 2001.